APOA2 Protein (AA 19-100) (His tag)

Produktnummer ABIN6809938

Produktdetails

Target: APOA2 (Apolipoprotein A-II (APOA2))

Protein-Typ: Recombinant

Proteineigenschaft: AA 19-100

Spezies: Human

Quelle: Escherichia coli (E. coli)

Aufreinigungstag / Konjugat: Dieses APOA2 Protein ist gelabelt mit His tag.

Sequenz: AA 19-100

Reinheit: >90 % as determined by SDS-PAGE.

Endotoxin-Niveau: Less than 1.0 EU per μg by the LAL method.

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Buffer: PBS, pH 7.4

Handhabung: Please avoid repeated freeze-thaw cycles.

Lagerung: -20 °C

Antigendetails

Target: APOA2 (Apolipoprotein A-II (APOA2))

Andere Bezeichnung: Apolipoprotein A-II (APOA2 Produkte)

Synonyme: Apo-AII Protein, ApoA-II Protein, apoAII Protein, Alp-2 Protein, ApoAII Protein, Apoa-2 Protein, Hdl-1 Protein, APOAII Protein, apoa2 Protein, apoA-II Protein, cb1032 Protein, wu:fb57h11 Protein, zgc:193613 Protein, apolipoprotein A2 Protein, apolipoprotein A-II Protein, APOA2 Protein, Apoa2 Protein, apoa2 Protein

Hintergrund: Apolipoprotein A-II(APO-A2) stabilize HDL (high density lipoprotein) structure by its association with lipids, and affect the HDL metabolism. It is produced by the liver and is involved in cholesteryl ester formation and cholesterol transport from tissues to the liver. Recent studies have established the interaction between APOA2 -256T>C polymorphism and dietary saturated fatty acids intake in relation to obesity on healthy individuals. Significant interaction between APOA2-saturated fatty acids intake and body mass index (BMI). The result of this study confirmed the interaction between APOA2 -256T>C polymorphism and SFAs intake with BMI in type 2 diabetic patients.

Molekulargewicht: 11.3 kDa

NCBI Accession: NP_001634

Pathways: Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Negative Regulation of Transporter Activity, Lipid Metabolism